Articles Posted in Featured Lawsuits

Earlier this month the FDA announced a major recall of prescription blood pressure and heart drugs which contain the active ingredient valsartan.  You can expect a large number of valsartan lawsuits to follow.

Valsartan is an active ingredient that is widely used in a number of brand name and generic drugs used to treat hypertension and heart failure.  It was recently discovered that when valsartan is manufactured in a certain way it can contain a dangerous impurity called N-nitrosodimethylamine (NMDA).

NMDA is a known human carcinogen.  The valsartan medications containing the dangerous NMDA impurity have been linked to a specific pharmaceutical ingredient distributed by a Chinese company — Zhejiang Huahai Pharmaceuticals.  Zhejiang Huahai was manufacturing the contaminated valsartan component and selling it to several U.S. pharmaceutical companies including Teva Pharmaceuticals Ltd. and Solco Healthcare.  Zhejiang Huahai discovered NMDA impurities in its product which eventually led to the FDA recall.

In August 2018, the FDA warned that sodium-glucosecotransporter-2 (SLGT2) inhibitors such as Invokana can cause a rare but serious infection that could result in an amputation of the genital area.

This is a big deal because Invokana is a commonly used diabetes medication. The list of diabetes drugs that have let patients down is long.  The money in these drugs is unreal.  To make the most money, you need to rush your product on the market without fully testing the drug.  That is the biggest problem.

Long before the FDA got involved, I have been looking at potential Invokana lawsuits.  These are the 11 questions victims have about Invokana and the Invokana litigation.

The Roundup weed killer cancer lawsuits have gather a lot of recent attention.  A $289 million verdict will do that.

These cases are now pushing along with great steam. U.S. District Judge Vince Chhabria in the Northern District of California is pushing to have MDL cases go before a federal jury by February 2019. Judge Chhabria has been presiding over all federal Roundup lawsuits. Many of these lawsuits allege that Monsanto failed to warn consumers that their Roundup weed killer brand might cause non-Hodgkin lymphoma and other cancers.

  1. Roundup

In 2000, Bayer Healthcare introduced the Mirena IUD, which is a flexible T-shaped RUD implant that is placed in the uterus for up to five years as a form of birth control.   It has been a relatively effective birth control device. It is even more effective in preventing pregnancy than even female sterilization.  But while effective for its intended purpose, a lot of problems have been reported with the Mirena IUD.  Since 2004, the FDA has received over 77,000 adverse event reports relating to Mirena.

Mirena IUD’s have been linked to shutterstock_130064462-229x300perforating uteri, and the IUD’s have been known to move out of position on occasion, causing internal injuries, with over 4,000 lawsuits pending from women.  The reality is these cases have either failing or have already failed.  It is unfair but our justice system is not always fair. Recently, however, a new type of lawsuit has started to arise regarding Mirena IUD’s and Bayer Healthcare Pharmaceuticals.

Pseudotumor Cerebri(PTC)

PTC is called many different things: idiopathic intracranial hypertension, pseudotumor cerebri, benign intracranial hypertension are the most common.  This serious condition is characterized by a buildup of fluid pressure on the brain. This fluid buildup results in severe headaches, vision loss, and possibly other problems.

PTC is most commonly in obese females of reproductive age.  The biggest symptom of PTC is papilledema.  Early symptoms include headaches and visual disturbances. Patients with these symptoms, particularly obese patients or those with recent weight gain, should be screened for papilledema and, if present, the patient should be referred to a neurologist for further diagnosis and care.  Continue reading

Jury verdict abortion malpractice

Juries have not been impressed with Johnson & Johnson’s Arguments

Out of nowhere, talcum powder ovarian cancer cases became the hottest mass tort case.  What happened and where are we now in these lawsuits?

The Product and the Big Question

For many decades, talcum powder has enjoyed great success as a consumer product. While young mothers often eagerly sprinkle it on their infants during diaper changes to help absorb wetness and prevent diaper rash, other women used the powdery substance as a regular part of their feminine hygiene practices.

Also, both male and female athletes routinely use talcum powder products to try and lower their chances of developing athlete’s foot and other fungal infections. Only limited complaints have been lodged for many years about the possibility that talcum powder could cause ovarian cancer. However, many women are now challenging their earlier beliefs about this product’s safety. In fact, the first successful lawsuit against talcum powder product giant, Johnson & Johnson, have now been filed and won.
Continue reading

NexiumPatients who experience acid indigestion, heartburn or other stomach ailments often seek relief from their symptoms by taking one or more drugs like Nexium.  Many patients have gotten great relief from heartburn and related symptoms which experience little if any side effects.

Those are the happy ending stories. But new research studies indicate that serious Nexium side effects (including kidney disease) can develop when prescribed or OTC (over-the-counter) heartburn medications are taken in higher doses — or for extended time periods.

Back in the 1980s when drugs like Nexium, Prilosec, and Prevacid were first marketed in the United States, many physicians believed they could benefit their patients because the risk of using the was outweighed by the benefits.  Growing scientific literature, including new studies published in 2016 in JAMA Internal Medicine and the Journal of the American Society of Nephrology, question that assumption. Continue reading

xarelto2I have written pretty extensively on this blog about the various lawsuits pertaining to the anticoagulant, Xarelto. This drug from Bayer is a controversial one, which has produced a history of bleeding injuries. Despite the risks, Xarelto is a best-selling drug, accounting for a huge amount of money flowing into Bayer’s coffers.

I love quarterly updates from these companies on litigation because they do give a sometimes honest view as to how these companies view the claims against them.  Bayer’s recent quarterly update discussed some of the realities of the drug.This update is a little old now.  Get a recent update and some rampant speculation on the value of these cases here.

  • Get a Winter 2018 Xarelto litigation status update here.  Sneak preview: things are changing quickly for plaintiffs.

Continue reading

3M and one of its subsidiaries, Arizant Healthcare, are facing some heat over their Bair Hugger warming blanket. Lawsuits are starting to be filed, suggesting that the company knew that use of the Bair Hugger could expose surgical patients to the risk of infection. Patients who underwent surgery for hip or knee replacements are at greatest risk of infection.

The Bair Huggerbair

The Bair Hugger is a fairly interesting and ingenious device. When under anesthesia, the core body temperature drops a few degrees. While only a minor fluctuation, this drop in body temperature causes bleeding to increase in addition to longer recovery times. To address this, an anesthesiologist developed the Bair Hugger back in the 1980s. The device is a blanket of sorts that wraps around the patient on the operating table, blowing warm air to regulate their body temperature. As a result, a surgical patient’s core temperature can be maintained at exactly 98.6, ensuring minimal bleeding and recovery time.

The device is incredibly popular considering that it sees use in around 90% of all major surgeries. It is estimated that there are around 50,000 Bair Huggers in use around the country, meaning they are somewhat of a mainstay in the modern operating room.

Continue reading

gelFor months now, we have been writing about the onslaught of information pouring in regarding testosterone therapy and the negative side-effects associated with its use.

Testosterone products, prescribed to treat low testosterone (“Low T”) in men, have become popular among young men seeking physical enhancement, as well as older men who want to counter signs of aging.  Research, however, shows that low testosterone treatments may double the risk of heart attack for young men with heart disease as well as for men 65 years of age and older, even those who have had no heart problems.  Is it worth the risk if not medically necessary?   The FDA says no.

Continue reading

The data that links Zofran and birth defects keeps piling up. Lawsuits have been filed against the drug’s manufacturer, GlaxoSmithKline, because they failed to warn pregnant women that the drug can cause injuries to their unborn children when taken during pregnancy.

  • Learn more about how to bring a Zofran lawsuit and how settlements of these claims might work

What is Zofran and what does it do?

sickwomanZofran is an excellent nausea drug that was originally approved for use in individuals who were undergoing surgery or chemotherapy. The nausea associated with these surgeries is unbearable, and Zofran does a wonderful job of helping people deal with the pain.

But the organizations that make drugs like Zofran are corporations, and what do corporations like to rake in? Profits. So naturally, GlaxoSmithKline tried to figure out other ways to increase their market share for Zofran. One of the ways it did this was to push the drug “off label” on pregnant women suffering from morning sickness. Given the effectiveness of the drug in fighting nausea, this seemed like a good idea. However, the FDA did not and has not approved the drug for such usage, which comes as no surprise given the threat of birth defects to unborn children of mothers on the drug.

Continue reading